CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 217 filers reported holding CHEMOCENTRYX INC in Q3 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $262,000 | -36.1% | 10,540 | -35.5% | 0.01% | -16.7% |
Q1 2022 | $410,000 | -36.2% | 16,334 | -7.4% | 0.01% | -25.0% |
Q4 2021 | $643,000 | +8.1% | 17,634 | -49.3% | 0.01% | 0.0% |
Q3 2021 | $595,000 | +44.4% | 34,756 | +13.0% | 0.01% | +60.0% |
Q2 2021 | $412,000 | – | 30,756 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
Birchview Capital, LP | 25,000 | $428,000 | 0.29% |